Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy (AFFIRM)
This study is ongoing, but not recruiting participants.
Study NCT00974311
Information provided by Medivation, Inc.
First Received on September 9, 2009.
Last Updated on November 15, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
